| Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat. | |
| | |
MedLine Citation:
|
PMID: 22234649 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIMS/HYPOTHESIS: Glucokinase activators (GKAs) are currently being developed as new therapies for type 2 diabetes and have been shown to enhance beta cell survival and proliferation in vitro. Here, we report the effects of chronic GKA treatment on the development of hyperglycaemia and beta cell loss in the male Zucker diabetic fatty (ZDF) rat, a model of type 2 diabetes with severe obesity. METHODS: Cell protection by GKA was studied in MIN6 and INS-1 cells exposed to hydrogen peroxide. Glucose homeostasis and beta cell mass were evaluated in ZDF rats dosed for 41 days with Cpd-C (a GKA) or glipizide (a sulfonylurea) as food admixtures at doses of approximately 3 and 10 mg kg(-1) day(-1). RESULTS: Incubation of MIN6 and INS-1 832/3 insulinoma cell cultures with GKA significantly reduced cell death and impairment of intracellular NADH production caused by exposure to hydrogen peroxide. Progression from prediabetes (normoglycaemia and hyperinsulinaemia) to overt diabetes (hyperglycaemia and hypoinsulinaemia) was significantly delayed in male ZDF rats by in-feed treatment with Cpd-C, but not glipizide. Glucose tolerance, tested in the fifth week of treatment, was also significantly improved by Cpd-C, as was pancreatic insulin content and beta cell area. In a limited immunohistochemical analysis, Cpd-C modestly and significantly enhanced the rate of beta cell proliferation, but not rates of beta cell apoptosis relative to untreated ZDF rats. CONCLUSIONS/INTERPRETATION: These findings suggest that chronic activation of glucokinase preserves beta cell mass and delays disease in the ZDF rat, a model of insulin resistance and progressive beta cell failure. |
| | |
Authors:
|
M Futamura; J Yao; X Li; R Bergeron; J-L Tran; E Zycband; J Woods; Y Zhu; Q Shao; H Maruki-Uchida; H Goto-Shimazaki; R B Langdon; M D Erion; J Eiki; Y-P Zhou |
Related Documents
:
|
8397219 - Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats.... 18642759 - Nerve electrophysiological changes in rats with early induced diabetes. 3663009 - Triacylglycerol lipase activities in isolated myocardial cells from chronically diabeti... 6139319 - Effects of synthetic rat c-peptide in normal and diabetic rats. 8723529 - Effect of gliclazide on the functional response to calcium in diabetic rat heart. 7481069 - Effects of enalapril treatment on gene expression of smooth muscle myosin heavy chain i... 17462919 - Activation of cpla2 and spla2 in astrocytes exposed to simulated ischemia in vitro. 19936419 - Current practice in the management of patients with type 2 diabetes mellitus in saudi a... 8252039 - Disruption of insulin-like growth factor 2 imprinting in beckwith-wiedemann syndrome. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-11 |
Journal Detail:
|
Title: Diabetologia Volume: - ISSN: 1432-0428 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0006777 Medline TA: Diabetologia Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Banyu Tsukuba Research Institute, MSD K.K., 3 Okubo, Tsukuba, Ibaraki, 300-26, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relationship of exercise volume to improvements of quality of life with supervised exercise training...
Next Document: Pseudomyxoma peritonei: some different sonographic findings.